Literature DB >> 2919902

Pneumothorax in cystic fibrosis: a 26-year experience.

M L Spector1, R C Stern.   

Abstract

We reviewed the records of all patients with cystic fibrosis and radiologically demonstrated pneumothorax at Rainbow Babies and Childrens Hospital between 1959 and 1987. There occurred 144 pneumothoraces, 71 right and 73 left, in 99 patients, 48 female and 51 male. The median survival from the date of the first pneumothorax was 29.9 months. Primary therapy included the following: observation; tube thoracostomy; tube thoracostomy with instillation of quinacrine hydrochloride, tetracycline, silver nitrate, or talc; or partial pleurectomy. Complications were minimal in each group. The surgical group did significantly better than all other groups except the group given talc. We conclude that pneumothorax is a late and ominous complication of cystic fibrosis. The primary treatment of pneumothorax should be partial pleurectomy. Talc instillation should be reserved for patients in respiratory failure who are too ill to undergo operation and for the occasional patient in whom surgical intervention fails.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2919902     DOI: 10.1016/0003-4975(89)90269-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  BTS guidelines for the management of spontaneous pneumothorax.

Authors:  M Henry; T Arnold; J Harvey
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 2.  Cystic fibrosis, pathophysiological and clinical aspects.

Authors:  H J Neijens; M Sinaasappel; R de Groot; J C de Jongste; S E Overbeek
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

Review 3.  The Genetics of Pneumothorax.

Authors:  Philip M Boone; Rachel M Scott; Stefan J Marciniak; Elizabeth P Henske; Benjamin A Raby
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

Review 4.  Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines.

Authors:  Kathleen J Ramos; Patrick J Smith; Edward F McKone; Joseph M Pilewski; Amy Lucy; Sarah E Hempstead; Erin Tallarico; Albert Faro; Daniel B Rosenbluth; Alice L Gray; Jordan M Dunitz
Journal:  J Cyst Fibros       Date:  2019-03-27       Impact factor: 5.482

5.  Use of a Heimlich flutter valve for pneumothorax in cystic fibrosis.

Authors:  F P Edenborough; I Hussain; D E Stableforth
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

Review 6.  Pneumothorax in cystic fibrosis.

Authors:  Ioannis P Kioumis; Konstantinos Zarogoulidis; Haidong Huang; Qiang Li; Georgios Dryllis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Antonis Papaiwannou; Sofia Lampaki; Konstantinos Porpodis; Bojan Zaric; Perin Branislav; Ioannis Mpoukovinas; George Lazaridis; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

7.  [Emergencies in adult mucoviscidosis patients].

Authors:  C Smaczny; T Born; T O F Wagner
Journal:  Internist (Berl)       Date:  2012-05       Impact factor: 0.743

8.  Pneumothorax associated with nontuberculous mycobacteria: A retrospective study of 69 patients.

Authors:  Masako Ueyama; Takanori Asakura; Kozo Morimoto; Ho Namkoong; Shuichi Matsuda; Takeshi Osawa; Makoto Ishii; Naoki Hasegawa; Atsuyuki Kurashima; Hajime Goto
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.